Nanjing Change To Inventory vs End Period Cash Flow Analysis

688273 Stock

26.13 0.14 0.54%

Nanjing Medlander financial indicator trend analysis is infinitely more than just investigating Nanjing Medlander Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanjing Medlander Medical is a good investment. Please check the relationship between Nanjing Medlander Change To Inventory and its End Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Medlander Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Change To Inventory vs End Period Cash Flow

Change To Inventory vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanjing Medlander Medical Change To Inventory account and End Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Nanjing Medlander's Change To Inventory and End Period Cash Flow is -0.25. Overlapping area represents the amount of variation of Change To Inventory that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Nanjing Medlander Medical, assuming nothing else is changed. The correlation between historical values of Nanjing Medlander's Change To Inventory and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Inventory of Nanjing Medlander Medical are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Change To Inventory i.e., Nanjing Medlander's Change To Inventory and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.25

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

End Period Cash Flow

Most indicators from Nanjing Medlander's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanjing Medlander Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Medlander Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 10.4 M, whereas Selling General Administrative is forecasted to decline to about 98.9 M.

	2021	2022	2023	2024 (projected)
Interest Expense	152.7K	300.9K	380.9K	255.7K
Interest Income	780.5K	9.3M	14.9M	15.6M

Interest Expense Interest Income

Nanjing Medlander fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Short Term Investments
Total Assets		0.87	0.98	1.0	0.92	0.94	0.89	0.99	0.85	0.73	-0.55	-0.59	0.99	0.92	0.8	0.96	-0.24	0.96	1.0	0.94	-0.74	1.0	0.99	1.0	0.93	0.72
Other Current Liab	0.87		0.8	0.87	0.6	0.82	0.6	0.92	0.48	0.41	-0.25	-0.36	0.86	0.71	0.93	0.92	-0.21	0.78	0.87	0.64	-0.8	0.9	0.86	0.91	0.64	0.31
Total Current Liabilities	0.98	0.8		0.97	0.94	0.98	0.96	0.96	0.88	0.81	-0.72	-0.7	0.97	0.98	0.8	0.96	-0.11	1.0	0.97	0.96	-0.79	0.96	0.97	0.96	0.93	0.79
Total Stockholder Equity	1.0	0.87	0.97		0.91	0.94	0.88	0.99	0.85	0.72	-0.54	-0.58	0.99	0.92	0.8	0.96	-0.25	0.96	1.0	0.93	-0.73	1.0	0.99	1.0	0.93	0.71
Property Plant And Equipment Net	0.92	0.6	0.94	0.91		0.85	0.95	0.87	0.99	0.9	-0.68	-0.73	0.92	0.9	0.54	0.81	-0.28	0.93	0.91	1.0	-0.54	0.88	0.92	0.88	0.99	0.94
Retained Earnings	0.94	0.82	0.98	0.94	0.85		0.93	0.94	0.79	0.69	-0.74	-0.59	0.91	0.98	0.88	0.98	0.08	0.98	0.94	0.88	-0.9	0.94	0.91	0.94	0.84	0.67
Accounts Payable	0.89	0.6	0.96	0.88	0.95	0.93		0.85	0.93	0.86	-0.86	-0.74	0.88	0.98	0.65	0.86	0.02	0.97	0.88	0.96	-0.72	0.86	0.88	0.85	0.92	0.89
Cash	0.99	0.92	0.96	0.99	0.87	0.94	0.85		0.79	0.67	-0.5	-0.54	0.98	0.9	0.85	0.98	-0.24	0.95	0.99	0.89	-0.77	1.0	0.98	1.0	0.89	0.65
Non Current Assets Total	0.85	0.48	0.88	0.85	0.99	0.79	0.93	0.79		0.89	-0.7	-0.7	0.85	0.87	0.42	0.72	-0.25	0.88	0.85	0.98	-0.45	0.8	0.85	0.8	0.98	0.96
Non Currrent Assets Other	0.73	0.41	0.81	0.72	0.9	0.69	0.86	0.67	0.89		-0.72	-0.95	0.8	0.76	0.36	0.64	-0.31	0.8	0.72	0.88	-0.42	0.69	0.8	0.68	0.85	0.96
Net Receivables	-0.55	-0.25	-0.72	-0.54	-0.68	-0.74	-0.86	-0.5	-0.7	-0.72		0.68	-0.54	-0.82	-0.46	-0.59	-0.43	-0.75	-0.54	-0.7	0.66	-0.51	-0.54	-0.5	-0.61	-0.74
Good Will	-0.59	-0.36	-0.7	-0.58	-0.73	-0.59	-0.74	-0.54	-0.7	-0.95	0.68		-0.69	-0.64	-0.34	-0.54	0.26	-0.68	-0.58	-0.72	0.42	-0.55	-0.69	-0.54	-0.66	-0.83
Common Stock Shares Outstanding	0.99	0.86	0.97	0.99	0.92	0.91	0.88	0.98	0.85	0.8	-0.54	-0.69		0.89	0.77	0.94	-0.34	0.95	0.99	0.93	-0.7	0.98	1.0	0.98	0.93	0.76
Non Current Liabilities Total	0.92	0.71	0.98	0.92	0.9	0.98	0.98	0.9	0.87	0.76	-0.82	-0.64	0.89		0.78	0.93	0.1	0.99	0.91	0.93	-0.83	0.91	0.89	0.9	0.89	0.78
Capital Lease Obligations	0.8	0.93	0.8	0.8	0.54	0.88	0.65	0.85	0.42	0.36	-0.46	-0.34	0.77	0.78		0.93	0.15	0.8	0.8	0.59	-0.96	0.84	0.77	0.84	0.55	0.27
Inventory	0.96	0.92	0.96	0.96	0.81	0.98	0.86	0.98	0.72	0.64	-0.59	-0.54	0.94	0.93	0.93		-0.05	0.96	0.96	0.85	-0.89	0.98	0.94	0.97	0.82	0.59
Other Current Assets	-0.24	-0.21	-0.11	-0.25	-0.28	0.08	0.02	-0.24	-0.25	-0.31	-0.43	0.26	-0.34	0.1	0.15	-0.05		-0.05	-0.26	-0.24	-0.36	-0.23	-0.34	-0.24	-0.32	-0.26
Total Liab	0.96	0.78	1.0	0.96	0.93	0.98	0.97	0.95	0.88	0.8	-0.75	-0.68	0.95	0.99	0.8	0.96	-0.05		0.96	0.95	-0.81	0.95	0.95	0.95	0.92	0.79
Net Invested Capital	1.0	0.87	0.97	1.0	0.91	0.94	0.88	0.99	0.85	0.72	-0.54	-0.58	0.99	0.91	0.8	0.96	-0.26	0.96		0.93	-0.73	1.0	0.99	1.0	0.93	0.72
Property Plant And Equipment Gross	0.94	0.64	0.96	0.93	1.0	0.88	0.96	0.89	0.98	0.88	-0.7	-0.72	0.93	0.93	0.59	0.85	-0.24	0.95	0.93		-0.59	0.9	0.93	0.9	0.99	0.92
Short Long Term Debt	-0.74	-0.8	-0.79	-0.73	-0.54	-0.9	-0.72	-0.77	-0.45	-0.42	0.66	0.42	-0.7	-0.83	-0.96	-0.89	-0.36	-0.81	-0.73	-0.59		-0.76	-0.7	-0.76	-0.52	-0.34
Total Current Assets	1.0	0.9	0.96	1.0	0.88	0.94	0.86	1.0	0.8	0.69	-0.51	-0.55	0.98	0.91	0.84	0.98	-0.23	0.95	1.0	0.9	-0.76		0.98	1.0	0.9	0.67
Capital Stock	0.99	0.86	0.97	0.99	0.92	0.91	0.88	0.98	0.85	0.8	-0.54	-0.69	1.0	0.89	0.77	0.94	-0.34	0.95	0.99	0.93	-0.7	0.98		0.98	0.93	0.76
Net Working Capital	1.0	0.91	0.96	1.0	0.88	0.94	0.85	1.0	0.8	0.68	-0.5	-0.54	0.98	0.9	0.84	0.97	-0.24	0.95	1.0	0.9	-0.76	1.0	0.98		0.9	0.66
Intangible Assets	0.93	0.64	0.93	0.93	0.99	0.84	0.92	0.89	0.98	0.85	-0.61	-0.66	0.93	0.89	0.55	0.82	-0.32	0.92	0.93	0.99	-0.52	0.9	0.93	0.9		0.9
Short Term Investments	0.72	0.31	0.79	0.71	0.94	0.67	0.89	0.65	0.96	0.96	-0.74	-0.83	0.76	0.78	0.27	0.59	-0.26	0.79	0.72	0.92	-0.34	0.67	0.76	0.66	0.9

Click cells to compare fundamentals

Nanjing Medlander Account Relationship Matchups

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Nanjing Stock

Balance Sheet is a snapshot of the financial position of Nanjing Medlander Medical at a specified time, usually calculated after every quarter, six months, or one year. Nanjing Medlander Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nanjing Medlander and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nanjing currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nanjing Change To Inventory vs End Period Cash Flow Analysis

Change To Inventory vs End Period Cash Flow

Change To Inventory vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Change To Inventory

End Period Cash Flow

Nanjing Medlander fundamental ratios Correlations

Nanjing Medlander Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

Other Information on Investing in Nanjing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity

Short Long Term Debt	- 0.96	Capital Lease Obligations
Good Will	- 0.95	Non Currrent Assets Other
Short Long Term Debt	- 0.9	Retained Earnings
Short Long Term Debt	- 0.89	Inventory
Net Receivables	- 0.86	Accounts Payable
Short Long Term Debt	- 0.83	Non Current Liabilities Total